세계의 약제-디바이스 병용 시장

The global market for drug-device combinations is expected to grow from $129.4 billion in 2024 and is projected to reach $199.8 billion by the end of 2029, at a compound annual growth rate (CAGR) of 9.1% during the forecast period of 2024 to 2029.

The drug/biologic-device combination products market is expected to grow from $86.4 billion in 2024 and is projected to reach $136.5 billion by the end of 2029, at a CAGR of 9.6% during the forecast period of 2024 to 2029.

The drug-biologic combination products market is expected to grow from $30.4 billion in 2024 and is projected to reach $46.0 billion by the end of 2029, at a CAGR of 8.6% during the forecast period of 2024 to 2029.

Report Scope:

The global market for drug-device combination is a rapidly expanding healthcare industry segment, encompassing products that integrate pharmaceutical drugs with medical devices to enhance treatment efficacy and patient convenience. The current report provides a comprehensive introduction and delves into the market for drug-device combinations. It examines market trends of these products, utilizing data from 2021, estimates for 2024 and projections of compound annual growth rates spanning 2024 through 2029 (forecast period) and regional markets of the drug-device combination product market. This report highlights drug-device combinations' current and future market potential and a detailed competitive environment analysis. It covers the regulatory scenario, drivers, restraints, challenges, opportunities, emerging technologies and sustainability in drug-device combinations. The report also covers market projections for 2029 and the market share for key market players. The report informs all market players, potential entrants, government agencies and other interested parties. It covers geographic regions in detail, so companies interested in expanding their geographic reach will also find this study helpful.

Report Includes:

• 40 data tables and 43 additional tables
• Overview of the global markets for drug-device combination (DDC) products and biological devices
• Analyses of global market trends, with market revenue data from 2021 to 2023, estimates for 2024, and projected CAGRs through 2029
• Estimate of the current market size and revenue prospects of the global market, along with a market share analysis by product type, application (disease area), and region
• Facts and figures pertaining to the market dynamics, current and emerging technologies, regulations, prospects, product recalls, pipeline products, and the expected impact of macroeconomic factors
• Review of the industry supply chain, using the Porter's Five Forces model, to analyze the micro- and macro environmental factors prevailing in the marketplace
• Overview of ESG developments and sustainability trends in the industry, with a focus on consumer attitudes, companies' ESG score rankings and their ESG practices
• An analysis of the industry structure, including companies' market shares, alliances, M&A activity and venture funding outlook
• Profiles of the leading market players, including Medtronic, Boston Scientific Corp., Stryker, Abbott, and BD

Table of Contents

Chapter 1 Executive Summary

• Market Outlook
• Scope of Report
• Market Summary

Chapter 2 Market Overview

• Market Insights
• Regulatory Landscape
• Patent Review
• Product Recalls
• Product Pipeline

Chapter 3 Market Dynamics

• Market Dynamics Snapshot
• Drivers
• Wide Range of Potential Applications of Combinations Products
• Growing Prevalence of Chronic Diseases
• Empowering Patients: Integrating Homecare Trends with Drug Delivery Advancements
• Restraints
• Device Reliability and Robustness
• Human Factors Testing
• Drug and Device Integration
• Accommodating Different Volumes
• Challenges
• Biological Safety Challenges in Drug-Device Combinations
• Regulatory Challenges
• Opportunities
• Technology advancements and Innovative Product Launches
• Continuous Growth
• Key Players Focusing on Inorganic Strategies in the Drug-Device Combination Products Market

Chapter 4 Market Segmentation Analysis

• Segmentation Breakdown
• Drug-Device Combinations Market by Product Type
• Drug/Biologic-Device Combination Products
• Drug-Biologic Drug-Device Combination Products
• Drug, Device and Biologic Combination Products
• Drug-Device Combinations Market by Application
• Cardiovascular Diseases
• Metabolic Disorders
• Respiratory Diseases
• Wound Care
• Oncology
• Orthopedic Conditions
• Others
• Geographic Breakdown
• Drug-Device Combinations Market, by Region
• North America
• Europe
• Asia-Pacific
• Rest of the World

Chapter 5 Emerging Trends and Technologies

• Overview
• AI in Drug-Device Combination
• Nanotechnology
• Computational Models and Simulation
• Human Organs-on-Chips: Revolutionizing Medical Research
• Implantable Drug Delivery Systems
• Wireless Implants
• Smart Drug Delivery Devices for 3D Printing
• Recent Approvals and Launch of Novel Drug-device Combination Products

Chapter 6 ESG Development

• Introduction
• ESG Sustainability in Drug-Device Combinations Market
• ESG Risk Ratings
• WHO Guidelines and Global Initiatives
• BCC Research Viewpoint

Chapter 7 Competitive Landscape

• Company Share Analysis
• Mergers, Acquisitions and Collaborations
• Strategic Alliances

Chapter 8 Appendix

• Methodology
• Sources
• Abbreviations
• Company Profiles
• 3M
• ABBOTT
• B. BRAUN SE
• BD
• BOSTON SCIENTIFIC CORP.
• JOHNSON & JOHNSON SERVICES INC.
• MEDTRONIC
• SMITH+NEPHEW
• STRYKER
• TERUMO CORP.